Form 4: Centene Director Acquires Shares, Details Holdings

Centene Corp. Director Theodore R. Samuels II reported the acquisition of 608 common shares and updated his beneficial ownership, including direct and indirect holdings, and stock options.

Summary

• Director Theodore R. Samuels II acquired 608 shares of Centene Corp. common stock on December 31, 2025, at a price of $0 per share.
• This transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading strategy.
• Following this transaction, Mr. Samuels directly owns 19,812.979 shares of common stock, which includes 3,579 restricted stock units subject to vesting requirements.
• Additionally, 32,000 shares are indirectly owned through a revocable family trust where Mr. Samuels serves as a co-trustee.
• Mr. Samuels also holds 10,000 direct common stock options with an exercise price of $80.57, exercisable from February 7, 2025, and expiring on February 7, 2032.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, especially under a 10b5-1 plan, is generally viewed as a neutral to slightly positive signal, indicating continued confidence in the company's future by an insider.

Positives

• A director increased their direct beneficial ownership of common stock by 608 shares, which can be interpreted as a sign of confidence.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a structured and pre-arranged trading strategy.

Risks

• 3,579 shares of directly owned common stock are restricted stock units subject to vesting requirements, meaning full ownership is contingent on future conditions.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• 32,000 shares of common stock are indirectly owned through a revocable family trust, of which Mr. Samuels serves as a co-trustee.

Stakeholder Impact

• Shareholders: The director's acquisition of shares may be interpreted as a positive signal of confidence in the company's future performance.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where a director acquired shares under a pre-arranged 10b5-1 plan. While insider buying can be a positive signal, the nature of this transaction (grant at $0, pre-planned) and its relatively small size compared to total holdings do not warrant a change in investment recommendation based solely on this filing. Investors should continue to hold and monitor broader company performance and market conditions.

Keywords

Centene, CNC, Form 4, insider trading, director, stock acquisition, beneficial ownership, stock options, restricted stock units, 10b5-1 plan